Abstract
The U.S. Alzheimer' s disease medication markets research service provides
revenue and patient forecasts, competitive analysis, market trends, product
analysis and strategies for growth. The market is segmented by product type
into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism
drugs. Each of the segments discusses in detail marketed products, revenue
forecasts, product pipeline and competitive structure.
Table of Contents
1 EXECUTIVE SUMMARY
2 TOTAL MARKET INTRODUCTION
- Research Scope and Segmentation
- Scope and Segmentation
- Research Methodology
- Disease Overview and Treatment Options
- Disease Overview
- Disease Progression
- Disease Causes and Risk Factors
- Disease Burden
- Diagnosis
- Treatment Overview
- Total Market Introduction
- Introduction
- Competitive Structure
- Market Engineering Measurements
- Unmet Needs in the Alzheimer' s Disease Medication Market
- Patient Forecasts
- Revenue Forecasts
- Market Share Analysis
- General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
- Strategies for Growth
- Strategic Recommendations
3 CHOLINESTERASE INHIBITORS MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- FDA-approved Products
- Pipeline Analysis
- Market Forecasts
- Aricept Forecast
- Exelon Forecast
- Razadyne Forecast
- Cholinesterase Inhibitors Market
- Market Share Analysis
4 NMDA RECEPTOR ANTAGONISTS MARKET
- Market Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- Namenda
- Pipeline Analysis
- Market Forecasts
5 NEW MECHANISM PRODUCTS IN DEVELOPMENT
- Overview
- Introduction
- Amyloid Plaque Inhibitors Pipeline Analysis
- Secretase Inhibitors Pipeline Analysis
- Immunotherapeutics Pipeline Analysis
- Other New Mechanism Drugs Pipeline Analysis
- Market Forecasts
- Alzhemed Forecast
- Flurizan Forecast
6 APPENDIX
- Decision Support Database
- Number of Alzheimer' s Patients
- Alzheimer' s Disease Deaths
- Total Healthcare Expenditure
- Male Population 65 and Above
- Female Population 65 and Above
| 
